Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BHANU VISVALINGAM

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1336132844
CMS profile
242315
Location
ORANGE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,042.77

97 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,042.77 97

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BHANU VISVALINGAM

NPI 1336132844 · CMS profile ID 242315

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

ORANGE CITY, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336132844?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BHANU VISVALINGAM, NPI 1336132844, CMS profile ID 242315. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336132844?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). BHANU VISVALINGAM, NPI 1336132844, CMS profile ID 242315. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336132844?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
BHANU VISVALINGAM, NPI 1336132844, CMS profile ID 242315, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1336132844?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

97 matching records · $2,042.77 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 97 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–97 of 97.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $29.4403/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223918906 CMS
PFIZER INC. $23.3703/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230578387 CMS
AstraZeneca Pharmaceuticals LP $25.1703/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206212479 CMS
Eisai Inc. $16.1903/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244466616 CMS
Janssen Biotech, Inc. $18.8803/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175179078 CMS
Novartis Pharmaceuticals Corporation $19.6303/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200578369 CMS
Celgene Corporation $24.5303/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516881 CMS
Janssen Biotech, Inc. $16.5103/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175178752 CMS
Incyte Corporation $16.7103/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226063045 CMS
TOLMAR, INC. $20.5203/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237019781 CMS
Novartis Pharmaceuticals Corporation $16.6803/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200578365 CMS
Novartis Pharmaceuticals Corporation $1.4003/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200578367 CMS
Astellas Pharma US Inc $22.0203/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238744294 CMS
Astellas Pharma US Inc $2.0303/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238744740 CMS
AstraZeneca Pharmaceuticals LP $24.3503/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207016080 CMS
Daiichi Sankyo Inc. $17.0403/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197053139 CMS
Celgene Corporation $28.3002/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516857 CMS
E.R. Squibb & Sons, L.L.C. $21.2802/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516863 CMS
Ipsen Biopharmaceuticals, Inc $17.7602/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208822706 CMS
Dendreon Pharmaceuticals LLC $24.4502/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245011521 CMS
Novartis Pharmaceuticals Corporation $19.2302/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200578363 CMS
Celgene Corporation $10.6902/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184516859 CMS
Incyte Corporation $21.5902/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226051960 CMS
Novartis Pharmaceuticals Corporation $19.1702/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200578355 CMS
SpringWorks Therapeutics, Inc. $14.1202/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232172101 CMS
Merck Sharp & Dohme LLC $31.2002/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238131295 CMS
BeiGene USA, Inc. $20.9702/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202880676 CMS
Merck Sharp & Dohme LLC $29.2502/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238312596 CMS
Geron Corporation $24.7402/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238895725 CMS
SOBI, INC $24.0302/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240244967 CMS
Gilead Sciences, Inc. $21.2302/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234514044 CMS
Janssen Biotech, Inc. $23.4002/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175179384 CMS
TerSera Therapeutics LLC $15.8902/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244054231 CMS
Daiichi Sankyo Inc. $22.0702/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197042441 CMS
PFIZER INC. $24.0902/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230579677 CMS
Dendreon Pharmaceuticals LLC $23.2202/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245011519 CMS
Novartis Pharmaceuticals Corporation $16.5002/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200578357 CMS
ABBVIE INC. $25.7201/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204653440 CMS
Incyte Corporation $24.2401/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226062434 CMS
Eisai Inc. $15.4901/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244466612 CMS
ABBVIE INC. $28.4401/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204653435 CMS
AstraZeneca Pharmaceuticals LP $29.0601/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207219607 CMS
Genentech USA, Inc. $18.9101/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211498449 CMS
PFIZER INC. $26.8501/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230608365 CMS
Blueprint Medicines Corporation $17.5501/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235812805 CMS
Daiichi Sankyo Inc. $22.9801/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197040067 CMS
SERVIER PHARMACEUTICALS LLC $15.8301/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229093184 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $25,817.67 27
PY2020 $114.30 1
PY2021 $255.26 2
PY2022 $144.00 3
PY2023 $2,059.80 11
PY2024 $33.80 1
PY2025 $2,042.77 97

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $590,985.77 69
PY2024 Principal investigator $207,349.47 13
PY2023 Principal investigator $903.60 3
PY2022 Principal investigator $28,902.05 6
PY2020 Principal investigator $37,479.71 11
PY2019 Principal investigator $27,219.81 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

69 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ModernaTX, Inc. $576.82 12/19/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964034
Principal investigator 1 ModernaTX, Inc. $20,859.74 12/19/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964048
Principal investigator 1 ModernaTX, Inc. $4,532.50 12/19/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964108
Principal investigator 1 Eli Lilly and Company $915.38 12/17/2025 Non-covered Recipient Entity
PROGRESSIVE MEDICAL CONCEPTS LLC
A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187888162
Principal investigator 1 Eli Lilly and Company $1,395.66 12/17/2025 Non-covered Recipient Entity
PROGRESSIVE MEDICAL CONCEPTS LLC
A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187889596
Principal investigator 1 ModernaTX, Inc. $5,330.22 11/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964120
Principal investigator 1 ModernaTX, Inc. $7,498.66 11/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964128
Principal investigator 1 ModernaTX, Inc. $3,848.00 11/20/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964012
Principal investigator 1 ModernaTX, Inc. $265.20 11/20/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964086
Principal investigator 1 ModernaTX, Inc. $5,130.79 10/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964090
Principal investigator 1 ModernaTX, Inc. $5,191.38 10/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964106
Principal investigator 1 ModernaTX, Inc. $8,652.30 09/29/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964020
Principal investigator 1 ModernaTX, Inc. $986.78 09/29/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964022
Principal investigator 1 ModernaTX, Inc. $4,967.62 09/29/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964088
Principal investigator 1 ModernaTX, Inc. $445.90 09/17/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964032
Principal investigator 1 ModernaTX, Inc. $1,456.00 09/17/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964052
Principal investigator 1 ModernaTX, Inc. $682.50 09/17/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964078
Principal investigator 1 ModernaTX, Inc. $2,102.10 09/15/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964016
Principal investigator 1 ModernaTX, Inc. $6,864.00 09/15/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964026
Principal investigator 1 ModernaTX, Inc. $3,217.50 09/15/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964036
Principal investigator 1 ModernaTX, Inc. $426.40 09/10/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964050
Principal investigator 1 ModernaTX, Inc. $5,185.18 08/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964060
Principal investigator 1 ModernaTX, Inc. $752.89 08/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964094
Principal investigator 1 ModernaTX, Inc. $288.41 08/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964104
Principal investigator 1 ModernaTX, Inc. $28,616.62 08/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964114
Principal investigator 1 ModernaTX, Inc. $20,516.60 08/11/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964110
Principal investigator 1 ModernaTX, Inc. $1,377.88 07/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964042
Principal investigator 1 ModernaTX, Inc. $2,960.34 07/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964046
Principal investigator 1 ModernaTX, Inc. $865.23 07/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964066
Principal investigator 1 ModernaTX, Inc. $8,075.48 06/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964058
Principal investigator 1 ModernaTX, Inc. $20,722.38 06/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964100
Principal investigator 1 ModernaTX, Inc. $4,242.42 06/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964102
Principal investigator 1 ModernaTX, Inc. $21,709.16 06/18/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252963998
Principal investigator 1 ModernaTX, Inc. $14,997.32 06/18/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964018
Principal investigator 1 ModernaTX, Inc. $4,695.67 06/18/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964054
Principal investigator 1 ModernaTX, Inc. $530.40 06/18/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964098
Principal investigator 1 ModernaTX, Inc. $265.20 06/04/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964092
Principal investigator 1 ModernaTX, Inc. $16,416.40 05/30/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964004
Principal investigator 1 ModernaTX, Inc. $21,053.93 05/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964024
Principal investigator 1 ModernaTX, Inc. $986.78 05/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964028
Principal investigator 1 ModernaTX, Inc. $752.89 05/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964062
Principal investigator 1 ModernaTX, Inc. $4,985.75 05/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964096
Principal investigator 1 ModernaTX, Inc. $23,072.80 04/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964122
Principal investigator 1 ModernaTX, Inc. $5,167.05 04/28/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964124
Principal investigator 1 ModernaTX, Inc. $12,113.22 03/24/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964030
Principal investigator 1 ModernaTX, Inc. $29,238.30 03/24/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964080
Principal investigator 1 ModernaTX, Inc. $4,695.67 03/24/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964112
Principal investigator 1 ModernaTX, Inc. $1,638.00 03/19/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964074
Principal investigator 1 ModernaTX, Inc. $265.20 03/07/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964010
Principal investigator 1 ModernaTX, Inc. $4,876.97 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964002
Principal investigator 1 ModernaTX, Inc. $28,429.80 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964006
Principal investigator 1 ModernaTX, Inc. $18,458.24 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964044
Principal investigator 1 ModernaTX, Inc. $18,517.59 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964064
Principal investigator 1 ModernaTX, Inc. $18,464.94 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964072
Principal investigator 1 ModernaTX, Inc. $6,855.03 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964082
Principal investigator 1 ModernaTX, Inc. $43,837.60 02/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964084
Principal investigator 1 ModernaTX, Inc. $58.50 02/07/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964040
Principal investigator 1 ModernaTX, Inc. $58.50 02/07/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964070
Principal investigator 1 ModernaTX, Inc. $585.00 02/07/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964076
Principal investigator 1 AstraZeneca Pharmaceuticals LP $18,270.00 02/05/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older No dispute reported 06/30/2026 1185555583
Principal investigator 1 ModernaTX, Inc. $35,070.08 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964000
Principal investigator 1 ModernaTX, Inc. $2,538.90 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964008
Principal investigator 1 ModernaTX, Inc. $2,884.10 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964014
Principal investigator 1 ModernaTX, Inc. $11,695.32 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964038
Principal investigator 1 ModernaTX, Inc. $752.89 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964056
Principal investigator 1 ModernaTX, Inc. $34,089.12 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964118
Principal investigator 1 ModernaTX, Inc. $1,595.44 01/27/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964126
Principal investigator 1 ModernaTX, Inc. $2,340.00 01/22/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH LLC
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964116
Principal investigator 1 ModernaTX, Inc. $75.13 01/13/2025 Non-covered Recipient Entity
UNITED MEDICAL RESEARCH
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis No dispute reported 06/30/2026 1252964068